(Q35704971)
Statements
Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients (English)
Patricia Pérez-Matute
Laura Pérez-Martínez
Javier Aguilera-Lizarraga